EP Patent

EP2131820A1 — Sulfone polymer compositions

Assigned to Genzyme Corp · Expires 2009-12-16 · 16y expired

What this patent protects

Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containi…

USPTO Abstract

Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containing copolymers and copolymer networks may be derived from a multi- amine monomer and a multifunctional sulfonyl-containing monomer comprising two or more amine-reactive groups.

Drugs covered by this patent

Patent Metadata

Patent number
EP2131820A1
Jurisdiction
EP
Classification
—
Expires
2009-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.